ATE147980T1 - Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4,-triaz nisethionat zur behandlung und vorbeugung von drogenabhaengigkeit,-toleranz und- sensibilisierung - Google Patents

Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4,-triaz nisethionat zur behandlung und vorbeugung von drogenabhaengigkeit,-toleranz und- sensibilisierung

Info

Publication number
ATE147980T1
ATE147980T1 AT93913346T AT93913346T ATE147980T1 AT E147980 T1 ATE147980 T1 AT E147980T1 AT 93913346 T AT93913346 T AT 93913346T AT 93913346 T AT93913346 T AT 93913346T AT E147980 T1 ATE147980 T1 AT E147980T1
Authority
AT
Austria
Prior art keywords
tolerance
dichlorophenyl
diamino
pct
nisethionate
Prior art date
Application number
AT93913346T
Other languages
English (en)
Inventor
Meire Nakamura-Craig
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929212495A external-priority patent/GB9212495D0/en
Priority claimed from GB939308654A external-priority patent/GB9308654D0/en
Application filed by Wellcome Found filed Critical Wellcome Found
Application granted granted Critical
Publication of ATE147980T1 publication Critical patent/ATE147980T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Addiction (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT93913346T 1992-06-12 1993-06-11 Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4,-triaz nisethionat zur behandlung und vorbeugung von drogenabhaengigkeit,-toleranz und- sensibilisierung ATE147980T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929212495A GB9212495D0 (de) 1992-06-12 1992-06-12
GB939308654A GB9308654D0 (en) 1993-04-27 1993-04-27 Therapeutic triazine compounds and use

Publications (1)

Publication Number Publication Date
ATE147980T1 true ATE147980T1 (de) 1997-02-15

Family

ID=26301060

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93913346T ATE147980T1 (de) 1992-06-12 1993-06-11 Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4,-triaz nisethionat zur behandlung und vorbeugung von drogenabhaengigkeit,-toleranz und- sensibilisierung

Country Status (23)

Country Link
US (1) US5801171A (de)
EP (1) EP0644763B1 (de)
JP (1) JP3439211B2 (de)
KR (1) KR100268823B1 (de)
AT (1) ATE147980T1 (de)
AU (1) AU688729B2 (de)
CA (1) CA2137782A1 (de)
CZ (1) CZ284061B6 (de)
DE (1) DE69307705T2 (de)
DK (1) DK0644763T3 (de)
ES (1) ES2097516T3 (de)
GB (1) GB2282326A (de)
GR (1) GR3022671T3 (de)
HR (1) HRP930964B1 (de)
IL (1) IL105986A (de)
MY (1) MY109330A (de)
NO (1) NO306451B1 (de)
NZ (1) NZ253260A (de)
SI (1) SI9300318A (de)
SK (1) SK279730B6 (de)
TW (1) TW284689B (de)
WO (1) WO1993025207A1 (de)
YU (1) YU48573B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9726987D0 (en) 1997-12-22 1998-02-18 Glaxo Group Ltd Compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR68380B (de) * 1979-06-01 1981-12-28 Wellcome Found
GB8613183D0 (en) * 1986-05-30 1986-07-02 Wellcome Found Triazine salt
GB9012312D0 (en) * 1990-06-01 1990-07-18 Wellcome Found Pharmacologically active cns compounds

Also Published As

Publication number Publication date
IL105986A0 (en) 1993-10-20
CA2137782A1 (en) 1993-12-23
HRP930964B1 (en) 2000-06-30
CZ312894A3 (en) 1995-07-12
EP0644763B1 (de) 1997-01-22
HRP930964A2 (en) 1996-02-29
DK0644763T3 (da) 1997-07-28
YU48573B (sh) 1998-12-23
DE69307705D1 (de) 1997-03-06
NZ253260A (en) 1997-05-26
GB2282326A (en) 1995-04-05
WO1993025207A1 (en) 1993-12-23
SI9300318A (en) 1994-03-31
CZ284061B6 (cs) 1998-08-12
YU41093A (sh) 1996-10-09
GB9423697D0 (en) 1995-01-11
NO306451B1 (no) 1999-11-08
JP3439211B2 (ja) 2003-08-25
JPH07507790A (ja) 1995-08-31
AU688729B2 (en) 1998-03-19
KR100268823B1 (ko) 2000-12-01
DE69307705T2 (de) 1997-05-22
ES2097516T3 (es) 1997-04-01
GR3022671T3 (en) 1997-05-31
IL105986A (en) 1998-12-06
KR950701814A (ko) 1995-05-17
NO944790L (no) 1994-12-09
AU4345293A (en) 1994-01-04
EP0644763A1 (de) 1995-03-29
SK279730B6 (sk) 1999-02-11
TW284689B (de) 1996-09-01
SK153494A3 (en) 1996-01-10
NO944790D0 (no) 1994-12-09
US5801171A (en) 1998-09-01
MY109330A (en) 1997-01-31

Similar Documents

Publication Publication Date Title
ATE164067T1 (de) Verwendung von riluzole zur behandlung von traumatischen neurologischen-schädigungen
ATE211384T1 (de) Verwendung von adenosinantagonisten zur vorbeugung und behandlung von pankreatitis und ulcera
ATE144420T1 (de) Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
PT758241E (pt) Utilizacao de certos derivados de acido metanobisfosfonico para impedir o desprendimento de proteses e a migracao de proteses
BR9306361A (pt) Agentes para o tratamento de desordens resultantes do abuso de substâncias
ATE147980T1 (de) Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4,-triaz nisethionat zur behandlung und vorbeugung von drogenabhaengigkeit,-toleranz und- sensibilisierung
ATE204476T1 (de) Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazi e zur herstrllung eines medikaments zur behandlung von bestimmten schmerzen und ödem
ATE200624T1 (de) Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis
GR3033061T3 (en) Use of benzonaphthalene derivatives to make medicaments for treating diseases of the central nervous system
ATE259657T1 (de) Kombination aus einem beta rezeptorblocker und einem opioid

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee